相关实验视频

Updated: Jul 25, 2025

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

一个阿尔茨海默氏病类别进展子组分类分析,使用ADNI的多元学习

Dustin van der Haar¹, Ahmed Moustafa^2,3, Samuel L Warren³

¹Academy of Computer Science and Software Engineering, University of Johannesburg, Gauteng, South Africa. dvanderhaar@uj.ac.za.

Scientific reports

|June 28, 2023

概括

研究人员利用患者数据的多重学习探索了阿尔茨海默病 (AD) 的进展. 研究结果显示,在现有的AD类别中,特别是在轻度认知障碍过渡期间,有明显的分类,这表明需要精细分类.

科学领域:

神经科学是一个神经科学.
数据科学数据科学数据科学
生物统计学生物统计学

背景情况:

阿尔茨海默病 (AD) 研究利用统计和机器学习方法来识别疾病模式.
了解认知测试,生物标志物和AD进展之间的相互作用仍然具有挑战性.
目前的AD分类可能无法完全捕捉疾病轨迹的细微差别.

研究的目的:

使用多种学习技术探索阿尔茨海默病神经成像计划 (ADNI) 数据.
在现有的阿尔茨海默病类别中确定潜在的子组.
评估发现的子类别的统计意义.

主要方法:

应用多元学习技术,包括光谱嵌入,多维缩放,Isomap,t-SNE,UMAP和稀疏无声自动编码器.
分析了低维嵌入,以确定聚类潜力.
使用Kruskal-Wallis H测试来确定子类别的统计学意义.

主要成果:

多重学习揭示了当前阿尔茨海默病类别中的不同的子组.
这些分组在轻度认知障碍的过渡期间尤其明显.
统计分析证实了这些发现的子类别的重要性.

结论:

现有的阿尔茨海默病类别表现出固有的子分组.
轻度认知障碍的过渡阶段显示出显著的异质性.
为了改善临床理解和治疗,可能需要进一步细化AD分期和分类.

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...